Каграманова Анна Валерьевна
Moscow Clinical Scientific Center · 155 works · 802 citations · h-index 11
Top works
- The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy
- Epidemiology of inflammatory bowel disease. State of the problem (review)
- Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study
- Clinical guidelines. Crohn’s disease (К50), adults
- Post COVID-19 irritable bowel syndrome
- Clinical and Demographic Features and Treatment Approaches for Inflammatory Bowel Diseases (Crohn’s Disease, Ulcerative Colitis) in the Russia. The Primery Results of the Analysis of the National Register
- Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study
- Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study
- Systemic manifestations of inflammatory bowel diseases
- Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn’s Disease: A Retrospective, Multicentre Study
- Psoriasis and inflammatory bowel diseases: pathogenetic pathways and the choice of biologic therapy (a literature review)
- Stem Cell Therapy for Perianal Crohn’s Disease
- Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study
- Personalized medicine in the treatment of inflammatory bowel diseases
- O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov
- Difficulties in differential diagnosis tuberculosis and Crohn's disease. Case report
- EXPERIENCE OF TOFACITINIB USING IN THERAPY OF ULCERATIVE COLITIS IN REAL CLINICAL PRACTICE
- Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities
- Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
- Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey